{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T10:48:06Z","timestamp":1781002086112,"version":"3.54.1"},"reference-count":42,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.ejso.2024.109498","type":"journal-article","created":{"date-parts":[[2024,11,24]],"date-time":"2024-11-24T02:15:57Z","timestamp":1732414557000},"page":"109498","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Perioperative management and survival outcomes following cytoreductive surgery in patients with peritoneal metastases from rectal cancer: A scoping review"],"prefix":"10.1016","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7161-6871","authenticated-orcid":false,"given":"Rapha\u00eblle","family":"Bri\u00e8re","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Julie","family":"Simard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9911-0108","authenticated-orcid":false,"given":"Fran\u00e7ois","family":"Rouleau-Fournier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Letarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1747-9057","authenticated-orcid":false,"given":"S\u00e9bastien","family":"Drolet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9607-6987","authenticated-orcid":false,"given":"Alexandre","family":"Brind\u2019Amour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"16","key":"10.1016\/j.ejso.2024.109498_bib1","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11164922","article-title":"Prognostic factors of survival in patients with peritoneal metastasis from colorectal cancer","volume":"11","author":"Mendoza-Moreno","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.ejso.2024.109498_bib2","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/782890","article-title":"Colorectal cancer: prevention and management of metastatic disease","volume":"2014","author":"Sugarbaker","year":"2014","journal-title":"BioMed Res Int"},{"issue":"6","key":"10.1016\/j.ejso.2024.109498_bib3","doi-asserted-by":"crossref","first-page":"e621","DOI":"10.3747\/co.27.6919","article-title":"Canadian guidelines on the management of colorectal peritoneal metastases","volume":"27","author":"Brind'Amour","year":"2020","journal-title":"Curr Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2024.109498_bib4","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1200\/JCO.22.01690","article-title":"Treatment of metastatic colorectal cancer: ASCO guideline","volume":"41","author":"Morris","year":"2023","journal-title":"J Clin Oncol"},{"issue":"8","key":"10.1016\/j.ejso.2024.109498_bib5","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1007\/s10434-999-0790-0","article-title":"Morbidity and mortality analysis of 200 treatments with cytoreductive surgery and hyperthermic intraoperative intraperitoneal chemotherapy using the coliseum technique","volume":"6","author":"Stephens","year":"1999","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"10.1016\/j.ejso.2024.109498_bib6","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.jamcollsurg.2006.08.024","article-title":"Analysis of prognostic factors in seventy patients having a complete cytoreduction plus perioperative intraperitoneal chemotherapy for carcinomatosis from colorectal cancer","volume":"203","author":"da Silva","year":"2006","journal-title":"J Am Coll Surg"},{"issue":"4","key":"10.1016\/j.ejso.2024.109498_bib7","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jnci.2018.10.004","article-title":"Peritoneal carcinomatosis in colorectal cancer: defining predictive factors for successful cytoreductive surgery and hyperthermic intraperitoneal chemotherapy - a pilot study","volume":"30","author":"Mahmoud","year":"2018","journal-title":"J Egypt Natl Cancer Inst"},{"issue":"20","key":"10.1016\/j.ejso.2024.109498_bib8","doi-asserted-by":"crossref","first-page":"3737","DOI":"10.1200\/JCO.2003.04.187","article-title":"Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer","volume":"21","author":"Verwaal","year":"2003","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.ejso.2024.109498_bib9","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1002\/bjs.4516","article-title":"Predicting the survival of patients with peritoneal carcinomatosis of colorectal origin treated by aggressive cytoreduction and hyperthermic intraperitoneal chemotherapy","volume":"91","author":"Verwaal","year":"2004","journal-title":"Br J Surg"},{"issue":"1","key":"10.1016\/j.ejso.2024.109498_bib10","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1186\/s12957-021-02374-4","article-title":"Does the primary tumour location affect the prognosis of patients with colorectal cancer peritoneal metastases treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy?","volume":"19","author":"Chen","year":"2021","journal-title":"World J Surg Oncol"},{"issue":"10","key":"10.1016\/j.ejso.2024.109498_bib11","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1007\/s12094-018-1857-9","article-title":"Peritoneal carcinomatosis arising from rectal or colonic adenocarcinoma treated with cytoreductive surgery (CRS) hyperthermic intraperitoneal chemotherapy (HIPEC): two different diseases","volume":"20","author":"Tonello","year":"2018","journal-title":"Clin Transl Oncol"},{"issue":"11","key":"10.1016\/j.ejso.2024.109498_bib12","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1007\/s11605-023-05833-3","article-title":"Perioperative and oncological outcomes of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal metastasis of rectal origin","volume":"27","author":"Benvenisti","year":"2023","journal-title":"J Gastrointest Surg"},{"issue":"11","key":"10.1016\/j.ejso.2024.109498_bib13","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1016\/j.ejso.2019.06.020","article-title":"Colic and rectal tumors with peritoneal metastases treated with cytoreductive surgery and HIPEC: one homogeneous condition or two different diseases? A systematic review and meta-analysis","volume":"45","author":"Tonello","year":"2019","journal-title":"Eur J Surg Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2024.109498_bib14","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S1470-2045(20)30599-4","article-title":"Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial","volume":"22","author":"Qu\u00e9net","year":"2021","journal-title":"Lancet Oncol"},{"issue":"11","key":"10.1016\/j.ejso.2024.109498_bib15","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1111\/codi.15003","article-title":"Prognostic factors influencing survival in patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for isolated colorectal peritoneal metastases: a systematic review and meta-analysis","volume":"22","author":"Narasimhan","year":"2020","journal-title":"Colorectal Dis"},{"key":"10.1016\/j.ejso.2024.109498_bib16","article-title":"Pelvic exenterations combined with cytoreductions for T4 rectal cancers with peritoneal metastasis: a safety analysis","author":"Kazi","year":"2023","journal-title":"ANZ J Surg"},{"issue":"3","key":"10.1016\/j.ejso.2024.109498_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15030858","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy with intra-operative radiotherapy for patients with locally advanced or locally recurrent rectal cancer and peritoneal metastases","volume":"15","author":"van de Vlasakker","year":"2023","journal-title":"Cancers"},{"issue":"10","key":"10.1016\/j.ejso.2024.109498_bib18","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1097\/DCR.0000000000002448","article-title":"Clinical and histopathologic features of 35 patients treated for colorectal peritoneal metastases who survived 5 years","volume":"66","author":"Ghabra","year":"2023","journal-title":"Dis Colon Rectum"},{"issue":"2","key":"10.1016\/j.ejso.2024.109498_bib19","doi-asserted-by":"crossref","first-page":"59","DOI":"10.4103\/JCRP.JCRP_32_21","article-title":"Comparison of survival outcomes using cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colon versus rectal cancer with peritoneal carcinomatosis in an asian medical center","volume":"9","author":"Yu","year":"2022","journal-title":"Journal of Cancer Research and Practice"},{"issue":"1","key":"10.1016\/j.ejso.2024.109498_bib20","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/codi.15378","article-title":"Pelvic exenteration combined with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for advanced primary or recurrent colorectal cancer with peritoneal metastases","volume":"23","author":"Brown","year":"2021","journal-title":"Colorectal Dis"},{"issue":"Suppl 1","key":"10.1016\/j.ejso.2024.109498_bib21","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/s13193-019-00882-0","article-title":"Pelvic exenteration with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS + HIPEC) for rectal cancer-case series with review of literature","volume":"10","author":"Shinde","year":"2019","journal-title":"Indian J Surg Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2024.109498_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbj.0000000000000020","article-title":"Individualized multimodal treatment strategy for metastatic rectal adenocarcinoma: case report","volume":"3","author":"Magalh\u00e3es","year":"2018","journal-title":"Porto Biomed J"},{"issue":"5","key":"10.1016\/j.ejso.2024.109498_bib23","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1002\/jso.24169","article-title":"Cytoreductive surgery and HIPEC offers similar outcomes in patients with rectal peritoneal metastases compared to colon cancer patients: a matched case control study","volume":"113","author":"Simkens","year":"2016","journal-title":"J Surg Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2024.109498_bib24","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/jso.24290","article-title":"Complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastasis in Norway: prognostic factors and oncologic outcome in a national patient cohort","volume":"114","author":"Fr\u00f8ysnes","year":"2016","journal-title":"J Surg Oncol"},{"issue":"9","key":"10.1016\/j.ejso.2024.109498_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0108509","article-title":"Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival for patients with peritoneal carcinomatosis from colorectal cancer: a phase II study from a Chinese center","volume":"9","author":"Huang","year":"2014","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.ejso.2024.109498_bib26","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1007\/s00066-012-0282-1","article-title":"Intraoperative radiotherapy and cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. Five consecutive case reports of locally advanced rectal cancer with synchronous peritoneal carcinomatosis","volume":"189","author":"Klaver","year":"2013","journal-title":"Strahlenther Onkol"},{"issue":"4","key":"10.1016\/j.ejso.2024.109498_bib27","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1245\/s10434-012-2787-3","article-title":"Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in peritoneal carcinomatosis from rectal cancer","volume":"20","author":"Votanopoulos","year":"2013","journal-title":"Ann Surg Oncol"},{"issue":"11","key":"10.1016\/j.ejso.2024.109498_bib28","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1007\/s00432-013-1517-y","article-title":"Peritoneal metastases of lower gastrointestinal tract origin:a comparative study of patient outcomes following cytoreduction and intraperitoneal chemotherapy","volume":"139","author":"Ung","year":"2013","journal-title":"J Cancer Res Clin Oncol"},{"issue":"5","key":"10.1016\/j.ejso.2024.109498_bib29","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1097\/SLA.0b013e3181d9765d","article-title":"A comparative study of complete cytoreductive surgery plus intraperitoneal chemotherapy to treat peritoneal dissemination from colon, rectum, small bowel, and nonpseudomyxoma appendix","volume":"251","author":"Elias","year":"2010","journal-title":"Ann Surg"},{"issue":"8","key":"10.1016\/j.ejso.2024.109498_bib30","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1001\/jamasurg.2021.1642","article-title":"Perioperative systemic therapy vs cytoreductive surgery and hyperthermic intraperitoneal chemotherapy alone for resectable colorectal peritoneal metastases: a phase 2 randomized clinical trial","volume":"156","author":"Rovers","year":"2021","journal-title":"JAMA Surg"},{"issue":"9","key":"10.1016\/j.ejso.2024.109498_bib31","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1097\/DCR.0000000000001762","article-title":"The American society of colon and rectal surgeons clinical practice guidelines for the management of rectal cancer","volume":"63","author":"You","year":"2020","journal-title":"Dis Colon Rectum"},{"issue":"1","key":"10.1016\/j.ejso.2024.109498_bib32","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1470-2045(20)30555-6","article-title":"Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial","volume":"22","author":"Bahadoer","year":"2021","journal-title":"Lancet Oncol"},{"issue":"5","key":"10.1016\/j.ejso.2024.109498_bib33","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S1470-2045(21)00079-6","article-title":"Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial","volume":"22","author":"Conroy","year":"2021","journal-title":"Lancet Oncol"},{"issue":"4","key":"10.1016\/j.ejso.2024.109498_bib34","doi-asserted-by":"crossref","first-page":"e766","DOI":"10.1097\/SLA.0000000000005799","article-title":"Locoregional failure during and after short-course radiotherapy followed by chemotherapy and surgery compared with long-course chemoradiotherapy and surgery: a 5-year follow-up of the RAPIDO trial","volume":"278","author":"Dijkstra","year":"2023","journal-title":"Ann Surg"},{"issue":"1","key":"10.1016\/j.ejso.2024.109498_bib35","first-page":"18","article-title":"The American Society of colon and rectal surgeons clinical practice guidelines for the management of rectal cancer 2023 supplement","volume":"67","author":"Langenfeld","year":"2024","journal-title":"Dis Colon Rectum"},{"issue":"7","key":"10.1016\/j.ejso.2024.109498_bib36","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1007\/BF02054444","article-title":"Anastomotic leak after double-stapled low colorectal resection","volume":"39","author":"Averbach","year":"1996","journal-title":"Dis Colon Rectum"},{"issue":"3","key":"10.1016\/j.ejso.2024.109498_bib37","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1056\/NEJMoa1708618","article-title":"Hyperthermic intraperitoneal chemotherapy in ovarian cancer","volume":"378","author":"van Driel","year":"2018","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.ejso.2024.109498_bib38","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/codi.15997","article-title":"Risk factors for anastomotic leakage after anterior resection for rectal cancer (RALAR study): a nationwide retrospective study of the Italian Society of Surgical Oncology Colorectal Cancer Network Collaborative Group","volume":"24","author":"Degiuli","year":"2022","journal-title":"Colorectal Dis"},{"issue":"8","key":"10.1016\/j.ejso.2024.109498_bib39","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1245\/s10434-017-5853-z","article-title":"Is fecal diversion needed in pelvic anastomoses during hyperthermic intraperitoneal chemotherapy (HIPEC)?","volume":"24","author":"Whealon","year":"2017","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2024.109498_bib40","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1245\/s10434-015-4674-1","article-title":"Stoma creation and reversal after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy","volume":"23","author":"Doud","year":"2016","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"10.1016\/j.ejso.2024.109498_bib41","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1016\/j.ejso.2021.02.017","article-title":"Rectal anastomosis and hyperthermic intraperitoneal chemotherapy: should we avoid diverting loop ileostomy?","volume":"47","author":"Brind'Amour","year":"2021","journal-title":"Eur J Surg Oncol"},{"issue":"12","key":"10.1016\/j.ejso.2024.109498_bib42","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1016\/j.ejso.2022.05.018","article-title":"Anastomotic leakage after cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) for colorectal cancer","volume":"48","author":"Feenstra","year":"2022","journal-title":"Eur J Surg Oncol"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S074879832401566X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S074879832401566X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T07:50:05Z","timestamp":1740124205000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S074879832401566X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S074879832401566X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2024.109498","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Perioperative management and survival outcomes following cytoreductive surgery in patients with peritoneal metastases from rectal cancer: A scoping review","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2024.109498","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109498"}}